Dennis Rassias, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Albany, NYNPI 1346227337
Payments from drug & device makers
Across 37 payments — averaging $115.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Johnson & Johnson$574
- W. L. Gore & Associates, Inc.$206
- Merck$180
- Davol Inc.$139
- Kls-martin L.p.$114
- plus $172 from 5 others
What the payments were for
- Travel & lodging$1,13226%
- Food & beverage$1,65639%
- Education$1,50035%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $2,904 |
| Johnson & Johnson(2 entities) | 8 | $574 |
| W. L. Gore & Associates, Inc. | 2 | $206 |
| Merck | 4 | $180 |
| Davol Inc. | 1 | $139 |
| Kls-martin L.p. | 5 | $114 |
| Boston Scientific | 3 | $91 |
| Tempus AI, Inc | 1 | $23 |
| AstraZeneca | 1 | $23 |
| Merit Medical Systems Inc | 1 | $21 |
| Pinnacle Biologics, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,628
- Phasix Mesh$139
- PROPATEN Vascular Graft$127
- KEYTRUDA$123
- Monarch Platform$107
- STRATAFIX$102
- EVICEL Fibrin Sealant (Human)$101
How this compares
$4,289 in reported general payments places this provider in the 50th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.
See all thoracic surgery (cardiothoracic vascular surgery) providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Combivent RespimatIpratropium/Albuterol Sulfate | 12 | $5,815 |
| Famotidine | 52 | $718 |
| Omeprazole | 15 | $165 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Albany
- Lewis BrittonAlbany$143K
- Aubrey GallowayNew York$5.7M
- Mathew WilliamsNew York$4.3M
- Nasser AltorkiNew York$2.2M
- Prasad AdusumilliNew York$2M
- Sanjay SamySyracuse$1.7M
- David AdamsNew York$1.6M
- Koji TakedaNew York$1.3M
- Gilbert TangNew York$1.2M
- Isaac GeorgeNew York$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.